Experiences with
Tirosint762 public posts
Want to take advantage of all our features? Just log in!
or
Road from Research to Clinic: Could New CLL Treatments Be Available Soon? (Patient Power Interviews Dr Jeff Sharman at ASH2013)
Andrew Schorr interviews Dr. Jeff Sharman, medical director of hematology research at The US Oncology Network, exploring the multitude of new and developing therapies for the treatment of CLL. Dr. Sharman provides an update about where we stand with recent approvals and emerging approaches--including
Update on Novel B-Cell Receptor Signaling Inhibitors from NCCN 8th Annual Congress on Hematologic Malignancies
The article below from OncLive, provides a high level overview of trials experience of the new drugs Ibrutinib, Idelalisib and IPI-145 by Jeffrey Jones, MD, from The Ohio State University to the NCCN 8th Annual Congress on Hematologic Malignancies. Brief mention is also made of the benefits observed